Multilingual speech translation clinical trial
Research Ethics Committee of the Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Ethics Review Number 10704-(4)
 Multilingual Speech Translation Technology Promotion Consortium
Established on October 26, 2015, with the goal of carrying out research and development over the five years from 2015 on multilingual speech translation technology that can enable communication without causing foreign visitors to Japan to feel the language barrier, with the goal of providing practical equipment by 2020.
Fujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 155,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE: 6702) reported consolidated revenues of 4.5 trillion yen (US$40 billion) for the fiscal year ended March 31, 2017. For more information, please see http://www.fujitsu.com.
Founded in 1968 as a wholly owned subsidiary of Fujitsu Limited, Fujitsu Laboratories Ltd. is one of the premier research centers in the world. With a global network of laboratories in Japan, China, the United States and Europe, the organization conducts a wide range of basic and applied research in the areas of Next-generation Services, Computer Servers, Networks, Electronic Devices and Advanced Materials. For more information, please see: http://www.fujitsu.com/jp/group/labs/en/.
Press ContactsPublic and Investor Relations Division
Technical ContactsFront Technologies Laboratory
Company:Fujitsu Laboratories Ltd.
All company or product names mentioned herein are trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and is subject to change without advance notice.
Date: 19 September, 2017
City: Kawasaki, Japan
Company: Fujitsu Laboratories Ltd.